SCT promoter methylation is a highly discriminative biomarker for lung and many other cancers
Adwait Sathe, Xiaotu Ma, Michael Zhang
The paper identifies SCT promoter methylation as a highly discriminative biomarker for lung and multiple other cancers, validated across various datasets and experimental methods.
bioRxiv · Aug 5, 2015Cancer Biology